The Global Antibody Purification Services Market is estimated to reach over USD 2.3 billion by 2030, exhibiting a CAGR of 11.6 % during the forecast period.
Antibodies are biological products with a wide range of academic and pharmaceutical research applications. Antibodies are created to neutralize or destroy antigens or pathogens, and they are the most visible indicator of adaptive immune responses. Augmented prevalence of infectious diseases and rising demand for protein therapeutics are expected to provide growth prospects for players operating in this market over the upcoming years. Increased demand for antigen-specific affinity in various applications is expected to enhance market demand. Antigen-specific affinity facilitates affinity purification in samples that primarily bind to a specific antigen molecule through their antigen-binding domain. The increasing focus of biopharmaceutical and biotechnology businesses on the manufacture of antibody-based therapies is one of the key components fueling the growth of the antibody purification service market over the upcoming years.
However, the high cost of antibody purification services and availability of synthetic chemicals, coupled with the COVID-19 outbreak, may limit the target market's growth during the forecast period. Furthermore, increasing R&D activities and investments by prominent players are factors expected to create lucrative growth opportunities over the forecast period.
The antibody purification services market is segmented based on types, purification methods and end-users. The Type of Antibody market is segmented as Monoclonal, Polyclonal and Others. The Purification Method market is segmented as Physic-Chemical, Class Specific and Antigen Affinity. Based on the end-user’s market is segmented as Hospitals and Clinics and Industry and Research Institutes.
Based on product, the Antigen Affinity segment is accounted as a significant contributor in the antibody purification services market.
The antigen affinity category is expected to hold a significant share in the global antibody purification services market in 2021. increased demand for antigen-specific affinity in various applications is expected to enhance market demand because antigen-specific affinity aids in affinity purification in samples that attach to a specific antigen molecule via their antigen-binding domain.
Monoclonal antibody segment witnessed growth at a rapid rate
The monoclonal antibody segment is projected to grow at a rapid rate in the global antibody purification services market during the forecast period due to increased investment in monoclonal antibody research and growing new product innovation, and the monoclonal antibody segment is predicted to be the most dominant segment in the antibody purification service market. Monoclonal antibodies offer a wide range of applications in diagnostics, therapeutics, and targeted drug delivery systems, resulting in new growth potential for the antibody purification services market, especially in the US, Germany, UK, China, and India.
The North American antibody purification services market holds a significant revenue share.
The North American antibody purification services market is expected to register the highest market share in terms of revenue soon. The increased incidence of cancer, government financing for medical research in the United States, the demand for high-quality cancer treatment, and regulatory approvals and permission for the use of abs in Canada are all significant market drivers. The antibody purification service market is expected to be fueled further by substantial growth in healthcare and research infrastructure and a growing focus on drug discovery in North America.
In addition, Asia Pacific is projected to grow at a rapid rate in the global antibody purification services market due to growing concerns about the environment, rapid industrialization, government initiatives, and increasing funding in various industries. The availability of less stringent rules for antibody development and production may further contribute to the growth of this region's antibody purification service market.
The key players in the antibody purification services market have shifted their focus towards bio-based components for product manufacturing and are initiating effective strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance product portfolio and strengthen their market footprint across the globe. Some of the major key players in the antibody purification services market are "Antibody Research Corporation, Bio-synthesis Incubi Solutions, Southern Biotech, Thermo Fisher Scientific, Virus’s Corporation, RD Biotic, Detail Bio-tech Co, Genseric, KMD Bioscience, Southern Biotic, GE healthcare, COVALA, Envi go, Rockland, Creative Biolabs, Abcam, BBI Solutions, Kare bay Bio, Huambo, Antibodies In, Proscar Incorporated, Proteogenic, Gangway Biotech, Inc., Covance Inc., Sino Biological Inc., Kaneka Neurogenetic S.A., Takara Bio Inc., Other Prominent Player.